Low-Toxicity Natural Killer Cell-Based Immunotherapy for NRAS-Driven Mucosal Melanoma: Advances in Immune Regenerative Medicine
{{output}}
Anorectal mucosal melanoma (AMM) poses a significant challenge as a rare and aggressive cancer with limited treatment options. The current standard treatments for AMM have notable drawbacks, often leading to disease recurrence and progression, ultimately resul... ...